In these moribund markets you have to move further out on the risk curve and look at more exotic currency pairs for vol and sizeable pip moves - my former place of birth's currency, the rand, doesn't disappoint in this regard. For example, the 14 period ATR currently reads just above 2000 pips. Price has retraced its risk-off losses from 2 weeks prior. There are a couple factors working in the rand’s favour – GDP re-estimation higher, healthier balance sheet of the national electricity provider Eskom, solid rebound in PMI. However, the rand does have a high beta to risk and there are new mutations arising, which if potent enough could sour risk sentiment again and hurt the rand. Additionally, when the Fed starts tightening the screws with their monetary policy (especially if the upcoming job reports are robust), we will see outflows and this will pressure the rand. Lastly, given the strong rallies we've seen in precious metals SA has achieved a significant current account surplus. However, going forward their terms of trade will get hit hard if oil moves higher and gold lower, which to me seems like the probable path for both assets as the Fed tightens (real yields higher - hurts gold) and the economy reopens.
The RSI hit overbought and signalled the near term top for price. Price is now just below its 200-day SMA and 50-day SMA. A golden cross/death cross looks imminent. There is horizontal support at the 14.5 level. Price is also below its lower trend line of the ascending channel. The target on the downside would be the strong 14.2 horizontal support. On the upside, weakness in the rand could see moves toward the round number of 15.
Global risk Warning CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading in CFDs. You should consider whether you understand how CFD
Also on:
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.